Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ

AI và sinh thiết lỏng để kiểm tra ung thư

Kiểm tra quá trình methyl hóa DNA không có tế bào, nguồn gốc tín hiệu ung thư, giới hạn kết quả dương tính và âm tính, kết quả thử nghiệm NHS-Galleri và trạng thái tư vấn của FDA.

Đường dẫn hướng dẫn liên quanAI và sinh thiết lỏng cho bệnh ung thư
Câu hỏi 1 của 8

What molecular pattern does the Galleri test described by FDA analyze?

Xem trước mọi câu hỏi8 câu hỏi

Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.

  1. What molecular pattern does the Galleri test described by FDA analyze?
    • Mutations in every cancer cell from a biopsy
    • Cancer-associated methylation patterns in cell-free DNA
    • Antibodies specific to all tumor types
    • Proteins measured only inside tumor tissue
  2. What does a Cancer Signal Origin result represent?
    • A pathology-confirmed tumor location
    • A guarantee that the predicted organ contains cancer
    • A prediction of the likely anatomic source of a detected signal
    • A map of all cells in the body
  3. What should follow a Cancer Signal Detected result?
    • A diagnostic workup recommended by qualified healthcare professionals
    • Immediate cancer treatment without more testing
    • A decision to stop other screenings
    • A repeat blood test in place of evaluation
  4. How should someone interpret No Cancer Signal Detected?
    • It proves no cancer is present
    • It confirms symptoms are harmless
    • It removes the need for future screening
    • It does not rule out cancer; continue guideline-recommended screening
  5. What happened to the NHS-Galleri trial’s primary endpoint?
    • The study proved fewer cancer deaths
    • The reduction in combined stage III and IV cancers was not achieved
    • The trial did not include a control group
    • The test replaced all standard screening
  6. What does a favorable FDA advisory committee vote mean?
    • It automatically authorizes commercial use
    • It guarantees Medicare coverage
    • It is a non-binding recommendation, not final FDA authorization
    • It replaces a premarket application
  7. Why can a test with high specificity still miss many cancers?
    • Sensitivity and specificity describe different error types
    • Specificity is the number of cancers found
    • A negative signal confirms all tumor types are absent
    • High specificity guarantees high sensitivity
  8. Which result would establish that screening saves lives?
    • A high cancer-origin prediction score alone
    • A single positive test result
    • A reduction in time to sequence a sample
    • Evidence of a mortality benefit in appropriately designed follow-up